510(k) K770942

PHADECODE DIFFERENTIAL FACTOR XA1 ASSAY by Pharmaseal Div., Baxter Healthcare Corp. — Product Code JBQ

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 21, 1977
Date Received
May 24, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antithrombin Iii Quantitation
Device Class
Class II
Regulation Number
864.7060
Review Panel
HE
Submission Type